Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.67
-0.36 (-5.12%)
Jun 27, 2025, 4:00 PM - Market closed
Wave Life Sciences Stock Forecast
Stock Price Forecast
According to 13 professional analysts, the 12-month price target for Wave Life Sciences stock ranges from a low of $10 to a high of $36. The average analyst price target of $20.15 forecasts a 202.10% increase in the stock price over the next year.
Price Target: $20.15 (+202.10%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 5 | 5 | 7 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 11 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $18 | Buy | Reiterates | $18 | +169.87% | Jun 23, 2025 |
| Raymond James | Raymond James | Buy Initiates $14 | Buy | Initiates | $14 | +109.90% | Jun 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $10 | Buy | Initiates | $10 | +49.93% | Apr 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +229.84% | Mar 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +229.84% | Mar 5, 2025 |
Financial Forecast
Revenue This Year
61.41M
from 108.30M
Decreased by -43.29%
Revenue Next Year
62.61M
from 61.41M
Increased by 1.94%
EPS This Year
-1.04
from -0.70
EPS Next Year
-1.05
from -1.04
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 98.7M | 147.5M | 402.2M | ||
| Avg | 61.4M | 62.6M | 148.5M | ||
| Low | 34.3M | n/a | 32.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -8.9% | 140.2% | 542.3% | ||
| Avg | -43.3% | 1.9% | 137.2% | ||
| Low | -68.3% | - | -48.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.81 | -0.70 | 0.27 | ||
| Avg | -1.04 | -1.05 | -0.66 | ||
| Low | -1.23 | -1.39 | -1.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.